<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">J Korean Med Sci</journal-id>
      <journal-id journal-id-type="publisher-id">JKMS</journal-id>
      <journal-title-group>
        <journal-title>Journal of Korean Medical Science</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">1011-8934</issn>
      <issn pub-type="epub">1598-6357</issn>
      <publisher>
        <publisher-name>The Korean Academy of Medical Sciences</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">20358009</article-id>
      <article-id pub-id-type="pmc">2844588</article-id>
      <article-id pub-id-type="doi">10.3346/jkms.2010.25.4.626</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
          <subj-group>
            <subject>Cell Therapy &amp; Organ Transplantation</subject>
          </subj-group>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Normalization of Red Cell Enolase Level Following Allogeneic Bone Marrow Transplantation in a Child with Diamond-Blackfan Anemia</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Park</surname>
            <given-names>Jeong A</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
          <xref ref-type="aff" rid="A2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Lim</surname>
            <given-names>Yeon Jung</given-names>
          </name>
          <xref ref-type="aff" rid="A3">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Park</surname>
            <given-names>Hyeon Jin</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kong</surname>
            <given-names>Sun Young</given-names>
          </name>
          <xref ref-type="aff" rid="A4">4</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Park</surname>
            <given-names>Byung Kiu</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Ghim</surname>
            <given-names>Thad T.</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
      </contrib-group>
      <aff id="A1"><label>1</label>Pediatric Oncology Center, National Cancer Center, Goyang, Korea.</aff>
      <aff id="A2"><label>2</label>Department of Pediatrics, Inje University Haeundae Paik Hospital, Busan, Korea.</aff>
      <aff id="A3"><label>3</label>Department of Pediatrics, Chungnam University Hospital, Daejeon, Korea.</aff>
      <aff id="A4"><label>4</label>Department of Diagnostic Laboratory Medicine, National Cancer Center, Goyang, Korea.</aff>
      <author-notes>
        <corresp>Address for Correspondence: Thad T. Ghim, M.D. Pediatric Oncology Center, National Cancer Center, 111 Jungbalsan-ro, Ilsandong-gu, Goyang 410-769, Korea. Tel: +82.31-920-1653, Fax: +82.31-920-1520, <email>thadghim@gmail.com</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <month>4</month>
        <year>2010</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>19</day>
        <month>3</month>
        <year>2010</year>
      </pub-date>
      <volume>25</volume>
      <issue>4</issue>
      <fpage>626</fpage>
      <lpage>629</lpage>
      <history>
        <date date-type="received">
          <day>02</day>
          <month>6</month>
          <year>2008</year>
        </date>
        <date date-type="accepted">
          <day>14</day>
          <month>11</month>
          <year>2008</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; 2010 The Korean Academy of Medical Sciences.</copyright-statement>
        <copyright-year>2010</copyright-year>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/3.0">
          <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/3.0">http://creativecommons.org/licenses/by-nc/3.0</ext-link>) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>We describe a girl with Diamond-Blackfan anemia with accompanying red cell enolase deficiency. At the age of 9 yr old, the patient received allogeneic bone marrow transplantation from her HLA-identical sister who had normal red cell enolase activity. While the post transplant DNA analysis with short tandem repeat has continuously demonstrated a stable mixed chimerism on follow-up, the patient remains transfusion independent and continues to show a steady increase in red cell enolase activity for over two and a half years following bone marrow transplantation.</p>
      </abstract>
      <kwd-group>
        <kwd>Anemia, Diamond-Blackfan</kwd>
        <kwd>Erythrocyte Enzyme Deficiency</kwd>
        <kwd>Red Cell Enolase Deficiency</kwd>
        <kwd>Bone Marrow Transplantation</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro">
      <title>INTRODUCTION</title>
      <p>Diamond-Blackfan anemia (DBA) is a chronic congenital hematological disease characterized by a selective erythroid regenerative defect (<xref ref-type="bibr" rid="B1">1</xref>). The hematological features of DBA include anemia, reticulocytopenia and bone marrow erythrocytopenia, and the main stay of treatment involves corticosteroid administration and blood transfusion. Although the majority of patients respond to steroids, some require long-term high-dose steroid therapy, and some of these patients develop steroid resistance and require chronic red cell transfusions.</p>
      <p>Red cell enolase deficiency is an enzymopathy, which has been sparsely reported. To the best of our knowledge, the association between DBA and red cell enolase deficiency has never been described in the literature. Rather, in DBA, red cell enzyme activities including enolase were reported to be above the normal mean (<xref ref-type="bibr" rid="B2">2</xref>). In this report, we describe a case of DBA with accompanying red cell enolase deficiency in a child, who after successful bone marrow transplantation (BMT) showed resolution of anemia as well as normalization of red cell enolase activity.</p>
    </sec>
    <sec sec-type="cases">
      <title>CASE REPORT</title>
      <p>A two-month-old baby girl was diagnosed as having DBA. Her physical examination was normal except for signs of anemia, and there was no associated skeletal anomaly. At presentation, her hemoglobin was 2.7g/dL, white blood cell count 3,260/&#xB5;L, platelet count 321,000/&#xB5;L and reticulocytes 0.42%. A peripheral blood smear showed macrocytic normochromic anemia with no evidence of hemolysis. A bone marrow evaluation at 10 weeks of age showed a marked decrease in erythropoiesis and maturation arrest of red cell precursors (<xref ref-type="fig" rid="F1">Fig. 1A</xref>). The estimated M:E ratio was 26.8:1. Serology for Parvovirus B19 or Epstein-Barr virus revealed no evidence of active infection (<xref ref-type="bibr" rid="B3">3</xref>). After establishing the diagnosis of DBA, the patient was treated with corticosteroid and showed good initial response. However, at 3 yr of age, she became steroid resistant and soon became transfusion dependent. She had usually been transfused every 4 to 8 weeks and required chelating treatment on a number of occasions. The anemia got progressively worsened and reticulocyte counts were low most of the time. Yet, unexplained reticulocytosis was occasionally seen (<xref ref-type="fig" rid="F2">Fig. 2</xref>).</p>
      <p>At 4 yr old, a further evaluation of her chronic anemia incidentally revealed very low enolase activity (0.04 IU/g Hb; Hb 4.0 g/dL) compared to normal control (normal control 5.19 IU/g Hb; Hb 13 g/dL) while erythrocyte adenosine deaminase level (eADA) was within normal range (1.5 IU/g Hb; normal control 1.6 IU/g Hb) (<xref ref-type="bibr" rid="B4">4</xref>). Other red cell enzyme activities were normal or slightly increased. Her mother and father had normal hemoglobin levels and normal mean corpuscular volume (MCV), but their enolase activities were subnormal. On the other hanad, the red cell enolase activity in her younger sister who subsequently donated marrow was normal (<xref ref-type="table" rid="T1">Table 1</xref>).</p>
      <p>At the age of 7 yr, the patient underwent an allogeneic BMT from her human leukocyte antigen (HLA) identical sister. The conditioning regimen was comprised of intravenous busulfan 3.2 mg/kg/day over 4 days followed by intravenous cyclophosphamide 60 mg/kg/day for 2 days and rabbit antithymocyte globulin 2.5 mg/kg/day for 3 days. A total of 2.92&#xD7;10<sup>8</sup>/kg unmanipulated BM nucleated cells (CD34+ cells: 3.58&#xD7;10<sup>6</sup>/kg) were infused. Methotrexate and cyclosporine A were given to prevent graft versus host disease (GVHD). Granulocyte colony-stimulating factor at 10 g/kg/day was administrated from day 5 to day 16. Neutrophil engraftment was achieved on day 15, and platelet engraftment on day 24. No transplant related morbidity occurred, e.g., infection, acute GVHD or veno-occlusive disease. Bone marrow aspirates on day 28 showed active trilineage hematopoiesis (<xref ref-type="fig" rid="F1">Fig. 1B</xref>) and mixed chimeric state (recipient DNA: 11.26%) on multiplex short tandem repeat analysis (STR) performed with the AmpFlSTR Blue polymerase chain reaction (PCR) amplification kit (PE Applied Biosystems, Foster City, CA, USA) (<xref ref-type="bibr" rid="B5">5</xref>). As hoped for, the enolase activity (0.72 IU/g Hb; normal control 3.4 IU/g Hb) on day 28 after BMT was higher than that of the low pre-transplant level (<xref ref-type="fig" rid="F3">Fig. 3</xref>). At one year after BMT, her red cell enolase level had risen further to 6.54 IU/g Hb (normal control 7.76 IU/g Hb), and DNA analysis of the bone marrow aspirates showed a persistent stable mixed chimerism (recipient DNA 5.08%). She had no longer required any blood transfusion ever since the time of BMT.</p>
    </sec>
    <sec sec-type="discussion">
      <title>DISCUSSION</title>
      <p>Enolase deficiency is extremely rare, and its pathogenesis, inheritance and clinical manifestation have not been firmly established. Enolase deficiency is known to be associated with chromosome 1p locus mutations (1 pter-p36.13) and to cause chronic nonspecific hemolytic anemia (<xref ref-type="bibr" rid="B6">6</xref>). Lachant et al. (<xref ref-type="bibr" rid="B7">7</xref>) described four generations of a Caucasian family with hereditary red cell enolase deficiency. They reported that this disease entity had a variety of clinical expression with autosomal dominant inheritance pattern. However, in our case, it doesn't seem to correspond to the reported inheritance pattern.</p>
      <p>DBA is also markedly heterogeneous with respect to pathogenesis, inheritance, and clinical manifestation. DBA is inherited in about 10-20% of cases, and genetic studies have identified mutations in RPS19 (a ribosomal protein gene) in a quarter of cases (<xref ref-type="bibr" rid="B8">8</xref>). Recent studies have also suggested some other associated genes, i.e., chromosomes 8p, 10q (RPS24), 1q31 and 15 (RPS17) (<xref ref-type="bibr" rid="B9">9</xref>-<xref ref-type="bibr" rid="B11">11</xref>). However, in other cases, genetic linkage with DBA has yet to be identified. This fact suggests its genetic heterogeneity. Unfortunately, genetic screening for the patient and her family was not performed at the time of diagnosis although it could have shed some light in the understanding of the relationship between enolase deficiency and DBA.</p>
      <p>Unlike the elevated erythrocyte enzyme activities reported both in hypoplasitic anemia and stress-induced environment of erythropoiesis (<xref ref-type="bibr" rid="B2">2</xref>), our patient had a very low enolase level, suggesting that DBA and enolase deficiency might also coexist. On the other hand, our patient may represent a hitherto undescribed disease entity expressing both defective erythropoiesis and enolase deficiency simultaneously.</p>
      <p>Unlike our patient described here, the eADA level is known to be generally high in DBA patients. However, the role of eADA in the pathogenesis of DBA has not been established (<xref ref-type="bibr" rid="B12">12</xref>).</p>
      <p>There's a report of successful BMT in a child with a red cell pyruvate kinase (PK) deficiency (<xref ref-type="bibr" rid="B13">13</xref>). After transplant, the patient achieved a complete donor chimerism, normal hemoglobin level and normal red cell PK activity. On the other hand, our patient showed stable mixed chimerism. In non-malignant hematological disorders, it is believed that complete replacement of the recipient's hematopoietic system is not necessarily required to improve the underlying disease state (<xref ref-type="bibr" rid="B14">14</xref>). Despite the danger of graft rejection in mixed chimerism, it is known that even a small degree of mixed chimerism may improve the disease status in some hematologic diseases (<xref ref-type="bibr" rid="B15">15</xref>, <xref ref-type="bibr" rid="B16">16</xref>). To date, there are too few case reports of HSCT therapy results in RBC enzymopathies. However, as demonstrated in our case, mixed chimerism at an 89-95% level may produce an acceptable outcome in the RBC enolase deficiency.</p>
      <p>In summary, the case presented here uniquely illustrates that both red cell aplasia and red cell enzymopathy might coexist, and that successful marrow engrafment even with the mixed chimerism might correct both defective erythropoiesis and the RBC enolase deficiency simultaneously.</p>
    </sec>
  </body>
  <back>
    <ack>
      <title>ACKNOWLEDGEMENT</title>
      <p>We thank the nursing staffs in the Hemtopoietic Stem Cell Transplantation Unit at the National Cancer Center, without whom this publication could have not been possible, and Dr. Hee-Jin Kim for assaying the red cell enzyme levels as well as giving valuable comments regarding enolase enzymopathy.</p>
    </ack>
    <ref-list>
      <ref id="B1">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Da Costa</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Willig</surname>
              <given-names>TN</given-names>
            </name>
            <name>
              <surname>Fixler</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Mohandas</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Tchernia</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Diamond-Blackfan anemia</article-title>
          <source>Curr Opin Pediatr</source>
          <year>2001</year>
          <volume>13</volume>
          <fpage>10</fpage>
          <lpage>15</lpage>
          <pub-id pub-id-type="pmid">11176237</pub-id>
        </element-citation>
      </ref>
      <ref id="B2">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wang</surname>
              <given-names>WC</given-names>
            </name>
            <name>
              <surname>Mentzer</surname>
              <given-names>WC</given-names>
            </name>
          </person-group>
          <article-title>Differentiation of transient erythroblastopenia of childhood from congenital hypoplastic anemia</article-title>
          <source>J Pediatr</source>
          <year>1976</year>
          <volume>88</volume>
          <fpage>784</fpage>
          <lpage>789</lpage>
          <pub-id pub-id-type="pmid">131849</pub-id>
        </element-citation>
      </ref>
      <ref id="B3">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sung</surname>
              <given-names>HJ</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>SJ</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>JH</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>KA</given-names>
            </name>
            <name>
              <surname>Choi</surname>
              <given-names>CW</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>BS</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>JS</given-names>
            </name>
          </person-group>
          <article-title>Persistent anemia in a patient with diffuse large B cell lymphoma: pure red cell aplasia associated with latent Epstein-Barr virus infection in bone marrow</article-title>
          <source>J Korean Med Sci</source>
          <year>2007</year>
          <volume>22</volume>
          <issue>Suppl</issue>
          <fpage>S167</fpage>
          <lpage>S170</lpage>
          <pub-id pub-id-type="pmid">17923747</pub-id>
        </element-citation>
      </ref>
      <ref id="B4">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Beutler</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Blume</surname>
              <given-names>KG</given-names>
            </name>
            <name>
              <surname>Kaplan</surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>L&#xF6;hr</surname>
              <given-names>GW</given-names>
            </name>
            <name>
              <surname>Ramot</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Valentine</surname>
              <given-names>WN</given-names>
            </name>
          </person-group>
          <article-title>International Committee for standardization in Haematology: recommended methods for red-cell enzyme analysis</article-title>
          <source>Br J Haematol</source>
          <year>1977</year>
          <volume>35</volume>
          <fpage>331</fpage>
          <lpage>340</lpage>
          <pub-id pub-id-type="pmid">857853</pub-id>
        </element-citation>
      </ref>
      <ref id="B5">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wallin</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Buoncristiani</surname>
              <given-names>MR</given-names>
            </name>
            <name>
              <surname>Lazaruk</surname>
              <given-names>KD</given-names>
            </name>
            <name>
              <surname>Fildes</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Holt</surname>
              <given-names>CL</given-names>
            </name>
            <name>
              <surname>Walsh</surname>
              <given-names>PS</given-names>
            </name>
          </person-group>
          <article-title>TWGDAM validation of the AmpFISTR blue PCR amplification kit for forensic casework analysis</article-title>
          <source>J Forensic Sci</source>
          <year>1998</year>
          <volume>43</volume>
          <fpage>854</fpage>
          <lpage>870</lpage>
          <pub-id pub-id-type="pmid">9670511</pub-id>
        </element-citation>
      </ref>
      <ref id="B6">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Boulard-Heitzmann</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Boulard</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Tallineau</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Boivin</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Tanzer</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Bois</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Barriere</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Decreased red cell enolase activity in a 40-year-old woman with compensated haemolysis</article-title>
          <source>Scand J Haematol</source>
          <year>1984</year>
          <volume>33</volume>
          <fpage>401</fpage>
          <lpage>404</lpage>
          <pub-id pub-id-type="pmid">6515323</pub-id>
        </element-citation>
      </ref>
      <ref id="B7">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lachant</surname>
              <given-names>NA</given-names>
            </name>
            <name>
              <surname>Jennings</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Tanaka</surname>
              <given-names>KR</given-names>
            </name>
          </person-group>
          <article-title>Partial erythrocyte enolase deficiency: a hereditary disorder with variable clinical expression</article-title>
          <source>Blood</source>
          <year>1986</year>
          <volume>65</volume>
          <fpage>55A</fpage>
        </element-citation>
      </ref>
      <ref id="B8">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Perdahl</surname>
              <given-names>EB</given-names>
            </name>
            <name>
              <surname>Naprstek</surname>
              <given-names>BL</given-names>
            </name>
            <name>
              <surname>Wallace</surname>
              <given-names>WC</given-names>
            </name>
            <name>
              <surname>Lipton</surname>
              <given-names>JM</given-names>
            </name>
          </person-group>
          <article-title>Erythroid failure in Diamond-Blackfan anemia is characterized by apoptosis</article-title>
          <source>Blood</source>
          <year>1994</year>
          <volume>83</volume>
          <fpage>645</fpage>
          <lpage>650</lpage>
          <pub-id pub-id-type="pmid">8298126</pub-id>
        </element-citation>
      </ref>
      <ref id="B9">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gazda</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Lipton</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Willig</surname>
              <given-names>TN</given-names>
            </name>
            <name>
              <surname>Ball</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Niemeyer</surname>
              <given-names>CM</given-names>
            </name>
            <name>
              <surname>Tchernia</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Mohandas</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Daly</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Ploszynska</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Orfali</surname>
              <given-names>KA</given-names>
            </name>
            <name>
              <surname>Vlachos</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Glader</surname>
              <given-names>BE</given-names>
            </name>
            <name>
              <surname>Rokicka-Milewska</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Ohara</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Baker</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Pospisilova</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Webber</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Viskochil</surname>
              <given-names>DH</given-names>
            </name>
            <name>
              <surname>Nathan</surname>
              <given-names>DG</given-names>
            </name>
            <name>
              <surname>Beggs</surname>
              <given-names>AH</given-names>
            </name>
            <name>
              <surname>Sieff</surname>
              <given-names>CA</given-names>
            </name>
          </person-group>
          <article-title>Evidence for linkage of familial Diamond-Blackfan anemia to chromosome 8p23.3-p22 and for non-19q non-8p disease</article-title>
          <source>Blood</source>
          <year>2001</year>
          <volume>97</volume>
          <fpage>2145</fpage>
          <lpage>2150</lpage>
          <pub-id pub-id-type="pmid">11264183</pub-id>
        </element-citation>
      </ref>
      <ref id="B10">
        <label>10</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cmejla</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Cmejlova</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Handrkova</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Petrak</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Pospisilova</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>Ribosomal protein S17 gene (RPS17) is mutated in Diamond-Blackfan anemia</article-title>
          <source>Hum Mutat</source>
          <year>2007</year>
          <volume>23</volume>
          <fpage>1178</fpage>
          <lpage>1182</lpage>
          <pub-id pub-id-type="pmid">17647292</pub-id>
        </element-citation>
      </ref>
      <ref id="B11">
        <label>11</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Quigley</surname>
              <given-names>JG</given-names>
            </name>
            <name>
              <surname>Gazda</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Yang</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Ball</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Sieff</surname>
              <given-names>CA</given-names>
            </name>
            <name>
              <surname>Abkowitz</surname>
              <given-names>JL</given-names>
            </name>
          </person-group>
          <article-title>Investigation of a putative role for FLVCR, a cytoplasmic heme exporter, in Diamond-Blackfan anemia</article-title>
          <source>Blood Cells Mol Dis</source>
          <year>2005</year>
          <volume>35</volume>
          <fpage>189</fpage>
          <lpage>192</lpage>
          <pub-id pub-id-type="pmid">15996880</pub-id>
        </element-citation>
      </ref>
      <ref id="B12">
        <label>12</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Willig</surname>
              <given-names>TN</given-names>
            </name>
            <name>
              <surname>P&#xE9;rignon</surname>
              <given-names>JL</given-names>
            </name>
            <name>
              <surname>Gustavsson</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Gane</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Draptchinskaya</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Testard</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Girot</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Debr&#xE9;</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>St&#xE9;phan</surname>
              <given-names>JL</given-names>
            </name>
            <name>
              <surname>Chenel</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Cartron</surname>
              <given-names>JP</given-names>
            </name>
            <name>
              <surname>Dahl</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Tchernia</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <collab>The DBA Working Group of Societe d'Immunologie Pediatrique (SHIP)</collab>
          <article-title>High adenosine deaminase level among healthy probands of Diamond Blackfan anemia (DBA) cosegregates with the DBA gene region on chromosome 19q13</article-title>
          <source>Blood</source>
          <year>1998</year>
          <volume>92</volume>
          <fpage>4422</fpage>
          <lpage>4427</lpage>
          <pub-id pub-id-type="pmid">9834249</pub-id>
        </element-citation>
      </ref>
      <ref id="B13">
        <label>13</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tanphaichitr</surname>
              <given-names>VS</given-names>
            </name>
            <name>
              <surname>Suvatte</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Issaragrisil</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Mahasandana</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Veerakul</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Chongkolwatana</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Waiyawuth</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Ideguchi</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>Successful bone marrow transplantation in a child with red blood cell pyruvate kinase deficiency</article-title>
          <source>Bone Marrow Transplant</source>
          <year>2000</year>
          <volume>26</volume>
          <fpage>689</fpage>
          <lpage>690</lpage>
          <pub-id pub-id-type="pmid">11041572</pub-id>
        </element-citation>
      </ref>
      <ref id="B14">
        <label>14</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Liesveld</surname>
              <given-names>JL</given-names>
            </name>
            <name>
              <surname>Rothberg</surname>
              <given-names>PG</given-names>
            </name>
          </person-group>
          <article-title>Mixed chimerism in SCT: conflict or peaceful coexistence?</article-title>
          <source>Bone Marrow Transplant</source>
          <year>2008</year>
          <volume>42</volume>
          <fpage>297</fpage>
          <lpage>310</lpage>
          <pub-id pub-id-type="pmid">18660844</pub-id>
        </element-citation>
      </ref>
      <ref id="B15">
        <label>15</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wu</surname>
              <given-names>CJ</given-names>
            </name>
            <name>
              <surname>Gladwin</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Tisdale</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Hsieh</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Law</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Biernacki</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Rogers</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Walters</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Zahrieh</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Antin</surname>
              <given-names>JH</given-names>
            </name>
            <name>
              <surname>Ritz</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Krishnamurti</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
          <article-title>Mixed haematopoietic chimerism for sickle cell disease prevents intravascular haemolysis</article-title>
          <source>Br J Haematol</source>
          <year>2007</year>
          <volume>139</volume>
          <fpage>504</fpage>
          <lpage>507</lpage>
          <pub-id pub-id-type="pmid">17910640</pub-id>
        </element-citation>
      </ref>
      <ref id="B16">
        <label>16</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Walters</surname>
              <given-names>MC</given-names>
            </name>
            <name>
              <surname>Patience</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Leisenring</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Rogers</surname>
              <given-names>ZR</given-names>
            </name>
            <name>
              <surname>Aquino</surname>
              <given-names>VM</given-names>
            </name>
            <name>
              <surname>Buchanan</surname>
              <given-names>GR</given-names>
            </name>
            <name>
              <surname>Roberts</surname>
              <given-names>IA</given-names>
            </name>
            <name>
              <surname>Yeager</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Hsu</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Adamkiewicz</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Kurtzberg</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Vichinsky</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Storer</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Storb</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Sullivan</surname>
              <given-names>KM</given-names>
            </name>
          </person-group>
          <article-title>Stable mixed hematopoietic chimerism after bone marrow transplantation for sickle cell anemia</article-title>
          <source>Biol Blood Marrow Transplant</source>
          <year>2001</year>
          <volume>7</volume>
          <fpage>665</fpage>
          <lpage>673</lpage>
          <pub-id pub-id-type="pmid">11787529</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
  <floats-group>
    <fig id="F1" position="float">
      <label>Fig. 1</label>
      <caption>
        <p>(<bold>A</bold>) Bone marrow aspirates before BMT showed normocellular marrow with markedly reduced erythropoiesis. (<bold>B</bold>) Bone marrow aspirates obtained 28 days after BMT showed active trilineage hematopoiesis accompanied with presence of erythropoietic precursors (arrows).</p>
      </caption>
      <graphic xlink:href="jkms-25-626-g001"/>
    </fig>
    <fig id="F2" position="float">
      <label>Fig. 2</label>
      <caption>
        <p>This graph displays the changes of the hemoglobin level and reticulocytes counts. While on prednisolone from 2 months to 39 months of age, the hemoglobin levels increased with transient reticulocytosis, but later gradually decreased. Since 3 yr of age, she had been intermittently transfused, usually every 4 to 8 weeks. She eventually developed transfusion dependency.</p>
      </caption>
      <graphic xlink:href="jkms-25-626-g002"/>
    </fig>
    <fig id="F3" position="float">
      <label>Fig. 3</label>
      <caption>
        <p>This graph displays the observed erythrocyte enolase level increase that occurred after BMT.</p>
      </caption>
      <graphic xlink:href="jkms-25-626-g003"/>
    </fig>
    <table-wrap id="T1" position="float">
      <label>Table 1</label>
      <caption>
        <p>Red cell enolase levels of the patient, her family members, and of normal controls. This table also shows the CBC results of the family members</p>
      </caption>
      <graphic xlink:href="jkms-25-626-i001"/>
      <table-wrap-foot>
        <fn>
          <p>CBC, complete blood count; MCV, mean corpuscular volume; MCH, mean corpuscular hemoglobin; BMT, bone marrow transplantation.</p>
        </fn>
      </table-wrap-foot>
    </table-wrap>
  </floats-group>
</article>
</pmc-articleset>
